NCT02467413View on ClinicalTrials.gov

BAC in Patient With Alzheimer's Disease or Vascular Dementia

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 30, 2017

Primary Completion Date

November 1, 2018

Study Completion Date

November 1, 2018

Conditions
Alzheimer's DiseaseVascular Dementia
Interventions
DRUG

BAC

(vapor fraction from seeds of Glycine max (L.) Merr. and composition thereof)

OTHER

BAC Matched Vehicle

BAC Matched Vehicle

Trial Locations (1)

704

National Cheng Kung University Hospital, Tainan City

Sponsors
All Listed Sponsors
collaborator

A2 Healthcare Taiwan Corporation

INDUSTRY

lead

Charsire Biotechnology Corp.

INDUSTRY